Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fusion Looking To Broaden FloSeal Franchise With Sponge Formulation

This article was originally published in The Gray Sheet

Executive Summary

Fusion Medical Technologies' FloSeal sponge, which can be used both in and out of the operating room, could expand the overall market for Fusion's line of hemostatic sealant products, the company says.

You may also be interested in...



Fusion Shipping FloSeal Hemostatic Sealant Following Dec. 8 FDA Approval

Fusion Medical Technologies commenced shipments of its FloSeal hemostatic sealant on Dec. 9 at a price of $125 for a 4 ml kit, following FDA approval Dec. 8.

Fusion Shipping FloSeal Hemostatic Sealant Following Dec. 8 FDA Approval

Fusion Medical Technologies commenced shipments of its FloSeal hemostatic sealant on Dec. 9 at a price of $125 for a 4 ml kit, following FDA approval Dec. 8.

Ethicon Surgifoam To Ship In Early Nov. At An Average Cost Of About $23

Johnson & Johnson's Ethicon unit plans to commence shipments of its Surgifoam absorbable gelatin sponge for use as a hemostat in early November following FDA approval Sept. 30 via premarket approval application.

Related Content

UsernamePublicRestriction

Register

MT012052

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel